27 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Endo gains OK for Chapter 11 bankruptcy reorganization https://seekingalpha.com/news/4081378-endo-gains-ok-chapter-11-bankruptcy-reorgaanization?source=feed_sector_healthcare Mar 19, 2024 - Endo International's bankruptcy plan has been approved by a court, allowing for the sale of assets and the reduction of debt. Read more here.
The Zacks Analyst Blog Highlights Novo Nordisk, Tesla, Airbnb, ONEOK and CDW https://www.zacks.com/stock/news/2240060/the-zacks-analyst-blog-highlights-novo-nordisk-tesla-airbnb-oneok-and-cdw?cid=CS-ZC-FT-press_releases-2240060 Mar 13, 2024 - Novo Nordisk, Tesla, Airbnb, ONEOK and CDW are part of the Zacks top Analyst Blog.
Top Research Reports for Novo Nordisk, Tesla & Airbnb https://www.zacks.com/commentary/2239296/top-research-reports-for-novo-nordisk-tesla-airbnb?cid=CS-ZC-FT-research_daily-2239296 Mar 12, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Tesla, Inc. (TSLA) and Airbnb, Inc. (ABNB).
ONEOK (OKE) Q4 2023 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2024/02/27/oneok-oke-q4-2023-earnings-call-transcript/?source=iedfolrf0000001 Feb 27, 2024 - OKE earnings call for the period ending December 31, 2023.
Here's What Key Metrics Tell Us About Oneok (OKE) Q4 Earnings https://www.zacks.com/stock/news/2232025/here-s-what-key-metrics-tell-us-about-oneok-oke-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2232025 Feb 26, 2024 - While the top- and bottom-line numbers for Oneok (OKE) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Oneok Inc. (OKE) Reports Next Week: Wall Street Expects Earnings Growth https://www.zacks.com/stock/news/2227986/oneok-inc-oke-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2227986 Feb 19, 2024 - Oneok (OKE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Q4 Earnings Scorecard and Fresh Analyst Reports for Nike, Airbnb & CVS Health https://www.zacks.com/commentary/2225415/q4-earnings-scorecard-and-fresh-analyst-reports-for-nike-airbnb-cvs-health?cid=CS-ZC-FT-research_daily-2225415 Feb 13, 2024 - Today's Research Daily features a real-time earnings season update and new research reports on NIKE (NKE), Airbnb (ABNB), CVS Health (CVS) and others.
Oneok Inc. (OKE) Rises As Market Takes a Dip: Key Facts https://www.zacks.com/stock/news/2225074/oneok-inc-oke-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2225074 Feb 12, 2024 - Oneok Inc. (OKE) closed the most recent trading day at $70.23, moving +1.72% from the previous trading session.
Plains All American (PAA) Q4 Earnings Top Estimates, Sales Lag https://www.zacks.com/stock/news/2224324/plains-all-american-paa-q4-earnings-top-estimates-sales-lag?cid=CS-ZC-FT-analyst_blog|earnings_article-2224324 Feb 09, 2024 - Plains All American's (PAA) fourth-quarter earnings increase year over year, while revenues decline. Total costs and expenses reduce during the same period.
OKYO Pharma gains on receiving FDA nod of IND for OK-101 in neuropathic corneal pain https://seekingalpha.com/news/4065121-okyo-pharma-gains-on-receiving-fda-nod-of-ind-for-ok-101-in-neuropathic-corneal-pain?source=feed_sector_healthcare Feb 09, 2024 - OKYO Pharma rose about 18% in premarket as the company announced that the U.S. Food and Drug Administration (FDA) cleared OK-101 as its first Investigational Ne

Pages: 123

<Page 2